For the seventh year running, Endocrine News talks to editors from Endocrine Society publications to get the endocrine discoveries of 2021 worth their weight in gold. Research never stops. Despite facing challenges related to social distancing, supply chain disruptions, and other pandemic-related problems this past year, scientists dug deep in the mines of endocrinology and...
The Endocrine Society advocates on behalf of our members, the patients they treat, and the science they research. Though our work in 2021 remained virtual, we successfully advocated for our policy priorities and raised the visibility of the value of endocrinology and endocrine research. Let’s look back at some of our wins from this year....
Endocrine Society calls for $46.4 billion in NIH appropriations. Congress missed an opportunity to secure long-term funding for life-saving medical research in the midst of the pandemic. Congress averted a government shutdown by passing a two-month-long Continuing Resolution (CR), but it only provides temporary funding for the National Institutes of Health (NIH) and other government...
On September 23, the Endocrine Society will join a group of scientific societies, academic institutions, and other biomedical research advocates as part of the 9th Annual Rally for Medical Research. Rally participants will call on the Congress to make funding for the National Institutes of Health (NIH) a national priority and raise awareness about the...
Diabetes Research Connection announces grants ranging from $25,000 to $50,000 for early-career scientists focused on type 1 diabetes research from those seeing funding for research aimed at finding a cure, prevention, and treatments. Diabetes Research Connection (DRC), a 501(c)(3) that connects early-career scientists and donors to fund research projects aimed at prevention, cure, and better care...
Endocrine Society Continues to Advocate for Insulin Affordability Congressional leaders are continuing to discuss legislative options to address the rising cost of prescription drugs and the Endocrine Society continues to be one of the most vocal advocates urging Congress to address insulin affordability this year. The path forward for passing legislation to lower drug costs...
When President Joe Biden’s budget for fiscal year 2022 was introduced this summer, many biomedical research advocates took note of a new line item that would direct $6.5 billion over three years to a new Advanced Research Projects Agency for Health (ARPA-H) to be housed at the National Institutes of Health (NIH). While we were...
The Endocrine Society has launched a series of educational briefings for congressional offices about endocrine research. On March 30, we hosted a virtual congressional briefing on COVID-19 and diabetes. Our panel included Congresswoman Kim Schrier (WA-08), the only U.S. Representative living with type 1 diabetes and a pediatrician; director of the National Institutes of...
For the seventh year running, Endocrine News talks to editors from Endocrine Society publications to get the endocrine discoveries of 2021 worth their weight in gold. Research never stops. Despite facing challenges related to social distancing, supply chain disruptions, and other pandemic-related problems this past year, scientists dug deep in the mines of endocrinology and...
